The NLRP3 inflammasome is activated following cerebral ischemia, and pharmacological inhibition of NLRP3-mediated inflammatory response can prevent the deterioration of cerebral function (Fann et al., 2013a,b). The gene discussed is NLRP3; the disease is Cerebral ischemia.